Raymond Tu, MD, discusses the considerations for implementing a new lower dose mammography system, including patient safety, market share, and cost.
[[{"type":"media","view_mode":"media_crop","fid":"11562","attributes":{"alt":"","class":"media-image media-image-left","id":"media_crop_9305716539806","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"205","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"margin: 5px; float: left;","title":" ","typeof":"foaf:Image"}}]]When United Medical Center in Washington, D.C., upgraded their film-screen mammography system, they had several factors to consider, including how to best meet the needs of their underserved patient population while keeping costs in mind.
The push to lower radiation dose was also a major factor, said Raymond Tu, chairman of the Radiology Department at UMC and president of the American College of Radiology's Washington, D.C., chapter. In this podcast, Tu discusses why UMC opted for Philips’ MicroDose Mammography system, which the company launched in North America last fall.
Here, Tu details:
• The unique needs of his patient population, and how that factored into the selection of a new technology,
• The desire to select a solution that would help the group’s market share in the area, and
• The constraining factors keeping the industry from doing more to implement lower dose technologies.
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Month, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
Multicenter CT Study Shows Benefits of Emerging Diagnostic Model for Clear Cell Renal Cell Carcinoma
May 15th 2024Combining clinical and CT features, adjunctive use of a classification and regression tree (CART) diagnostic model demonstrated AUCs for detecting clear cell renal cell carcinoma (ccRCC) that were 15 to 22 percent higher than unassisted radiologist assessments.
CT Study: AI Algorithm Comparable to Radiologists in Differentiating Small Renal Masses
May 14th 2024An emerging deep learning algorithm had a lower AUC and sensitivity than urological radiologists for differentiating between small renal masses on computed tomography (CT) scans but had a 21 percent higher sensitivity rate than non-urological radiologists, according to new research.